Fortis Healthcare shares hit an new all-time high of Rs 927.75 on the BSE in Tuesday's opening trade, climbing as much as 0.75%.
Financial Performance:
Fortis Healthcare has demonstrated consistent financial performance over the recent years. The consolidated revenue for the quarter-ending June 2025 stood at Rs 2,166.72 Crore, compared to Rs 1,858.90 Crore in June 2024. The net profit for the same period was Rs 263.86 Crore, up from Rs 173.39 Crore in the previous year. The EPS (Earnings Per Share) increased to Rs 3.45 in June 2025 from Rs 2.20 in June 2024.
Here's a detailed look at the quarterly financial performance:
Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|
Revenue | Rs 1,858.90 Crore | Rs 1,988.39 Crore | Rs 1,928.26 Crore | Rs 2,007.20 Crore | Rs 2,166.72 Crore |
Net Profit | Rs 173.39 Crore | Rs 188.85 Crore | Rs 252.24 Crore | Rs 183.38 Crore | Rs 263.86 Crore |
EPS | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 |
Below is a summary of the yearly financial performance:
Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenue | Rs 4,030.12 Crore | Rs 5,717.61 Crore | Rs 6,297.63 Crore | Rs 6,892.92 Crore | Rs 7,782.75 Crore |
Net Profit | -103.73 Crore | Rs 765.80 Crore | Rs 611.15 Crore | Rs 635.71 Crore | Rs 797.86 Crore |
EPS | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 |
BVPS | 88.98 | 92.83 | 107.30 | 113.33 | 118.11 |
ROE | -1.79 | 8.98 | 8.12 | 7.81 | 8.68 |
Debt to Equity | 0.19 | 0.16 | 0.10 | 0.11 | 0.25 |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Sales | Rs 7,782 Crore | Rs 6,892 Crore | Rs 6,297 Crore | Rs 5,717 Crore | Rs 4,030 Crore |
Other Income | Rs 66 Crore | Rs 38 Crore | Rs 61 Crore | Rs 27 Crore | Rs 46 Crore |
Total Income | Rs 7,849 Crore | Rs 6,931 Crore | Rs 6,359 Crore | Rs 5,744 Crore | Rs 4,076 Crore |
Total Expenditure | Rs 6,669 Crore | Rs 5,951 Crore | Rs 5,438 Crore | Rs 4,634 Crore | Rs 3,915 Crore |
EBIT | Rs 1,179 Crore | Rs 979 Crore | Rs 920 Crore | Rs 1,110 Crore | Rs 161 Crore |
Interest | Rs 184 Crore | Rs 130 Crore | Rs 129 Crore | Rs 146 Crore | Rs 165 Crore |
Tax | Rs 197 Crore | Rs 212 Crore | Rs 180 Crore | Rs 197 Crore | Rs 99 Crore |
Net Profit | Rs 797 Crore | Rs 635 Crore | Rs 611 Crore | Rs 765 Crore | -103 Crore |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
---|---|---|---|---|---|
Sales | Rs 2,166 Crore | Rs 2,007 Crore | Rs 1,928 Crore | Rs 1,988 Crore | Rs 1,858 Crore |
Other Income | Rs 15 Crore | Rs 19 Crore | Rs 20 Crore | Rs 13 Crore | Rs 13 Crore |
Total Income | Rs 2,182 Crore | Rs 2,027 Crore | Rs 1,949 Crore | Rs 2,001 Crore | Rs 1,871 Crore |
Total Expenditure | Rs 1,764 Crore | Rs 1,727 Crore | Rs 1,626 Crore | Rs 1,708 Crore | Rs 1,607 Crore |
EBIT | Rs 417 Crore | Rs 299 Crore | Rs 322 Crore | Rs 293 Crore | Rs 264 Crore |
Interest | Rs 69 Crore | Rs 67 Crore | Rs 45 Crore | Rs 36 Crore | Rs 35 Crore |
Tax | Rs 83 Crore | Rs 48 Crore | Rs 25 Crore | Rs 67 Crore | Rs 56 Crore |
Net Profit | Rs 263 Crore | Rs 183 Crore | Rs 252 Crore | Rs 188 Crore | Rs 173 Crore |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Operating Activities | Rs 1,423 Crore | Rs 1,100 Crore | Rs 822 Crore | Rs 865 Crore | Rs 485 Crore |
Investing Activities | -779 Crore | -886 Crore | -373 Crore | -514 Crore | -135 Crore |
Financing Activities | -713 Crore | -86 Crore | -471 Crore | -517 Crore | -142 Crore |
Others | 0 | -2 | 1 | 13 | 4 |
Net Cash Flow | -69 Crore | Rs 124 Crore | -21 Crore | -152 Crore | Rs 212 Crore |
Equities & Liabilities | |||||
---|---|---|---|---|---|
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
Share Capital | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore | Rs 754 Crore |
Reserves & Surplus | Rs 8,161 Crore | Rs 6,906 Crore | Rs 6,485 Crore | Rs 5,423 Crore | Rs 5,362 Crore |
Current Liabilities | Rs 1,607 Crore | Rs 3,170 Crore | Rs 1,425 Crore | Rs 1,269 Crore | Rs 1,233 Crore |
Other Liabilities | Rs 3,167 Crore | Rs 2,457 Crore | Rs 3,767 Crore | Rs 4,437 Crore | Rs 3,803 Crore |
Total Liabilities | Rs 13,691 Crore | Rs 13,288 Crore | Rs 12,433 Crore | Rs 11,884 Crore | Rs 11,154 Crore |
Assets | |||||
Fixed Assets | Rs 6,636 Crore | Rs 6,221 Crore | Rs 5,513 Crore | Rs 5,485 Crore | Rs 5,242 Crore |
Current Assets | Rs 1,471 Crore | Rs 1,420 Crore | Rs 1,406 Crore | Rs 1,133 Crore | Rs 1,036 Crore |
Other Assets | Rs 5,584 Crore | Rs 5,646 Crore | Rs 5,514 Crore | Rs 5,265 Crore | Rs 4,875 Crore |
Total Assets | Rs 13,691 Crore | Rs 13,288 Crore | Rs 12,433 Crore | Rs 11,884 Crore | Rs 11,154 Crore |
Other Info | |||||
Contingent Liabilities | Rs 3,136 Crore | Rs 2,999 Crore | Rs 2,834 Crore | Rs 2,607 Crore | Rs 1,936 Crore |
Corporate Actions:
Fortis Healthcare's 29th Annual General Meeting (AGM) was held on August 11, 2025. The company appointed M/S Neelam Gupta & Associates as Secretarial Auditors for a 5-year term. The company announced a final dividend of Rs 1.00 per share (10%) on May 20, 2025, with an effective date of July 25, 2025.
Moneycontrol analysis indicates a very bullish sentiment on Fortis Healthcare as of August 12, 2025.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.